What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Klotho Neurosciences expands beyond the anti-aging gene with Turn Biotechnologies acquisition plan Klotho Neurosciences moves to buy Turn Bio’s ERA and eTurna assets plus a $300M Korea pharma deal. Explore how this could reshape its longevity pipeline. byPallavi MadhirajuSeptember 30, 2025